D. Tsitoura

发表

Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells

P. Rothman, D. Tsitoura, 2004 .

Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells.

P. Rothman, D. Tsitoura, 2004, The Journal of clinical investigation.

Intranasal exposure to protein antigen induces immunological tolerance mediated by functionally disabled CD4+ T cells.

J. Lamb, D. Umetsu, R. DeKruyff, 1999, Journal of immunology.

Immunomodulation

D. Tsitoura, Yannis Tassios, 2006, Annals of the New York Academy of Sciences.

Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma.

Stephen A. Smith, L. Lazarides, D. Mallett, 2016, Journal of medicinal chemistry.

Induction of anergy in human T helper 0 cells by stimulation with altered T cell antigen receptor ligands.

J. Lamb, A. Cerwenka, W. Holter, 1996, Journal of immunology.

Critical role of B cells in the development of T cell tolerance to aeroallergens.

D. Umetsu, R. DeKruyff, D. Tsitoura, 2002, International immunology.

Respiratory Infection with Influenza A Virus Interferes with the Induction of Tolerance to Aeroallergens1

K. Dabbagh, D. Lewis, D. Umetsu, 2000, The Journal of Immunology.

Regulation of cytokine production by human Th0 cells following stimulation with peptide analogues: differential expression of TGF‐β in activation and anergy

J. Lamb, D. Kemeny, C. Gelder, 1997, Immunology.

Aeroallergenswith the Induction of Tolerance to Respiratory Infection with Influenza A Virus

David Bruce Lewis, K. Dabbagh, D. Umetsu, 2013 .

Peptide-Mediated Regulation of Allergic Diseases

J. Lamb, G. Hoyne, C. Hetzel, 1996 .

Safety and pharmacodynamics of intranasal GSK2245035, a TLR7 agonist for allergic rhinitis: A randomized trial

A. Ellis, W. Powley, D. Tsitoura, 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

An intranasal nanoparticle STING agonist has broad protective immunity against respiratory viruses and variants

Manu Sebastian, A. Saeedi, Mohsen Fathi, 2022, bioRxiv.

Early clinical evaluation of the intranasal TLR7 agonist GSK2245035: Use of translational biomarkers to guide dosing and confirm target engagement

K. Biggadike, C. Ambery, W. Powley, 2015, Clinical pharmacology and therapeutics.

Allergen-Induced Airway Hyperreactivity Is Diminished in CD81-Deficient Mice1

S. Levy, D. Umetsu, Jun Deng, 2000, The Journal of Immunology.

Diminished in CD 81-Deficient Mice Allergen-Induced Airway Hyperreactivity Is

S. Levy, D. Umetsu, Jun Deng, 2000 .

Mechanisms preventing allergen-induced airways hyperreactivity: role of tolerance and immune deviation.

G. Berry, D. Umetsu, R. Blumenthal, 2000, The Journal of allergy and clinical immunology.

T Cells by Functionally Disabled CD4 Induces Immunological Tolerance Mediated Intranasal Exposure to Protein Antigen

J. Lamb, D. Umetsu, R. DeKruyff, 1999 .

Provocation of nonallergic rhinitis subjects in response to simulated weather conditions using an environmental exposure chamber model.

J. Bernstein, A. Salapatek, V. Nelson, 2012, Allergy and asthma proceedings.

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy

S. Durham, M. Shamji, Max Kirtland, 2020, Frontiers in Immunology.

Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model

D. Jackson, W. Zeng, M. Carroll, 2020, bioRxiv.

Altered T cell ligands derived from a major house dust mite allergen enhance IFN-gamma but not IL-4 production by human CD4+ T cells.

J. Lamb, A. Verhoef, C. Gelder, 1996, Journal of immunology.

Immunomodulation

D. Tsitoura, Yannis Tassios, 2006 .

Inhibition of capsaicin-driven nasal hyper-reactivity by SB-705498, a TRPV1 antagonist.

W. Fokkens, C. V. van Drunen, J. Denyer, 2014, British journal of clinical pharmacology.